Skip to main content

What the FDA labels say about taking them together

Carisoprodol and omeprazole

Carisoprodol's FDA label of July 15, 2025 names omeprazole in its drug interactions section; the omeprazole labels PlainMeds reads (2) do not name carisoprodol. The carisoprodol label: “Co-administration of CYP2C19 inhibitors, such as omeprazole or fluvoxamine, with carisoprodol could result in increased exposure of carisoprodol and decreased exposure of meprobamate.”

Check it at the source: the carisoprodol FDA label on DailyMed (effective July 15, 2025, Mylan Pharmaceuticals Inc.); the omeprazole FDA label on DailyMed (effective April 22, 2024, Apotex Corp).

What does the carisoprodol label say about omeprazole?

Carisoprodol label, drug interactions

Co-administration of CYP2C19 inhibitors, such as omeprazole or fluvoxamine, with carisoprodol could result in increased exposure of carisoprodol and decreased exposure of meprobamate.

Source: FDA drug label (Carisoprodol), Mylan Pharmaceuticals Inc., effective July 15, 2025 (SPL set 7c9184c0-7a2e-11df-8c8d-0002a5d5c51b), via openFDA; the full label on DailyMed

What does the omeprazole label say about carisoprodol?

Omeprazole's label (effective April 22, 2024) and its 1 other brand-application label do not name carisoprodol in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (Omeprazole), Apotex Corp, effective April 22, 2024 (SPL set b83329ac-a65e-b3af-a3fb-c5a6c740e5e7), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

24Carisoprodol generic labelers
118Omeprazole generic labelers
CarisoprodolOmeprazole
Labeled forMuscle spasms and spasticityAcid reflux and ulcers
Boxed warningNoNo
Pharmacy cost (NADAC)$0.0706 per tablet 350 mg tablet$0.0295 per capsule 20 mg capsule
Shortage nowNo current entryA presentation being discontinued

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?